DEXLANSOPRAZOLE Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses
Dexlansoprazole
IUPAC nomenclature
(R)-(+)-2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole
Classification
- Proton pump inhibitors
Physiochemical Properties
S. NO. | PHYSICAL AND CHEMICAL PROPERTIES | |
1 | Molecular weight | 369.4 g/mol |
2 | Physical appearance | White to brownish-white crystalline powder |
3 | Melting point | 140oC |
4 | Solubility | 0.21 mg/ml |
5 | Octanol/water partition coefficient | 2.38 |
5 | Presence of ring | Pyridine. Benzimidazole |
6 | Number of chiral centers | Not present |
Mechanism of Action
- Dexlansoprazole is a prodrug which requires protonation via an acidic environment to get activated form Sulphenamide.
- Sulphenamide covalently binds with cystien residues via disulfide bridges on the α subunit of H/K ATPase enzyme system.
- Thereby it inhibits the H+/K+ ATPase pump which in turn inhibits the gastric acid secretion or formation of hydrochloric acid in parietal cells
Structure Activity Relationship
General structure activity of Heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]Pyridine derivatives acting as acid pump antagonists can be summarized as:
- The inhibitory property of drugs depends on hydrophobic group substituted at the left side ortho-position of the phenyl ring.
- Increase in hydrophobic value increases the activity.
- Increasing the GTCI value decreases the activity.
- Small molecule substitutions may participate in hydrophobic interaction as well as steric interactions. [1]
Method of synthesis
TAP’s group synthesized the Dexlansoprazole through the following scheme: [2]
Medicinal Uses
Dexlansoprazole is used for treatment of:
- Stomach ulcers
- Active duodenal ulcers
- Active benign gastric ulcer
- GERD
- Erosive esophagitis
- Zollinger-Errison syndrome
Side Effects
Side effects of Dexlansoprazole are:
- Abdominal pain
- Nausea
- Constipation
- Headache
- Low magnesium blood level
- Irregular heartbeat
- Muscle spasms
- Seizures
- Lupus
- Diarrhea
- Blood in stool
MCQs
Q.1 Mechanism of action of Dexlansoprazole drug includes?
a) Protonation into sulphenamide
b) Conversion into hydroxyzine
c) Vasoconstriction
d) Agonist effects H1 receptor for Histamine
Q.2 Medicinal use of drug Dexlansoprazole is/are?
a) Stomach ulcers
b) Watery eyes
c) Sneezing
d) Hives
Q.3 Select the correct option from below related with the General structure activity of Heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]Pyridine derivatives acting as acid pump antagonists-
a) The inhibitory property of drugs depends on hydrophobic group substituted at the left side ortho-position of the phenyl ring.
b) Increase in hydrophobic value decreases the activity.
c) Increasing the GTCI value increases the activity.
d) All of the above
Q.4 Number of chiral carbons present in the structure of Dexlansoprazole is?
a) 0
b) 1
c) 2
d) 3
Q.5 Correct sequence for the True/False for the physiochemical properties of the drug dexlansoprazole can be?
- Molecular weight: 952.3 gm/mol
- Physical appearance: Yellow crystalline powder
- Octanol/water partition coefficient: 2.38
a) TTT
b) TFT
c) FFT
d) TFF
Q.6 Correct statements for the IUPAC nomenclatures of the drugs are?
I. Dexlansorazole: 2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine
II. Loxapine: (3-methylpyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole.
III. Gluthethmide: 4-Chlorophenyl)phenylmethyl-1-piperazinyl]ethoxy]acetic acid
IV. Tolazoline: 2-Benzyl-4,5-dihydro-1H-imidazole
a) I, II
b) III, IV
c) IV
d) I, II, III, IV
Q.7 Match the following drugs with their correct classifications-
i. Dexlansoprazole | A. Proton pump inhibitor |
ii. Ibuprofen | B. Sedative-hypnotic |
iii. Naloxone | C. Anti-inflammatory |
iv. Chlordiazepoxide | D. Narcotic antagonist |
a) i-A, ii-C, iii-D, iv-B
b) i-D, ii-A, iii-C, iv-B
c) i-D, ii-B, iii-A, iv-C
d) i-B, ii-D, iii-A, iv-C
Participate in Online FREE GPAT TEST: CLICK HERE
Participate in Online FREE Pharmacist TEST: CLICK HERE
Participate in Online FREE Drug Inspector TEST: CLICK HERE
Participate in CSIR NET JRF Mock Test
ANSWERS
1-a
2-a
3-a
4-a
5-c
6-c
7-a